Literature DB >> 24140915

Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.

Tetiana Matviiuk1, Frédéric Rodriguez, Nathalie Saffon, Sonia Mallet-Ladeira, Marian Gorichko, Ana Luisa de Jesus Lopes Ribeiro, Maria Rosalia Pasca, Christian Lherbet, Zoia Voitenko, Michel Baltas.   

Abstract

We report here the discovery, synthesis and screening results of a series of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives as a novel class of potent inhibitors of Mycobacterium tuberculosis H37Rv strain as well as the enoyl acyl carrier protein reductase (ENR) InhA. Among them, several compounds displayed good activities against InhA which is one of the key enzymes involved in the type II fatty acid biosynthesis pathway of the mycobacteria cell wall. Furthermore, some exhibited promising activities against M. tuberculosis and multi-drug resistant M. tuberculosis strains.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  3-(9H-Fluoren-9-yl)pyrrolidine-2,5-dione; InhA; Inhibition; Mycobacterium tuberculosis; Succinimide

Mesh:

Substances:

Year:  2013        PMID: 24140915     DOI: 10.1016/j.ejmech.2013.09.041

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  Boris V Nikonenko; Albert Kornienko; Konstantin Majorov; Pavel Ivanov; Tatiana Kondratieva; Maria Korotetskaya; Alexander S Apt; Elena Salina; Valeriya Velezheva
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Computational studies of metal carbonyl complexes of 3[4-ethyl(phenly)imino][indoline-2-one] and 3[4-butyl(phenly)imino][indoline-2-one].

Authors:  Nursel Acar; Sevil Şener
Journal:  J Mol Model       Date:  2018-06-22       Impact factor: 1.810

3.  Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis.

Authors:  Md Imtiazul Islam; Hoonhee Seo; Sukyung Kim; Venkata S Sadu; Kee-In Lee; Ho-Yeon Song
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 4.  Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents.

Authors:  Nilesh Gajanan Bajad; Sudhir Kumar Singh; Sushil Kumar Singh; Tryambak Deo Singh; Meenakshi Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-07-16

5.  Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2.

Authors:  Junie B Billones; Maria Constancia O Carrillo; Voltaire G Organo; Stephani Joy Y Macalino; Jamie Bernadette A Sy; Inno A Emnacen; Nina Abigail B Clavio; Gisela P Concepcion
Journal:  Drug Des Devel Ther       Date:  2016-03-11       Impact factor: 4.162

6.  Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.

Authors:  Paulo F M Oliveira; Brigitte Guidetti; Alain Chamayou; Christiane André-Barrès; Jan Madacki; Jana Korduláková; Giorgia Mori; Beatrice Silvia Orena; Laurent Roberto Chiarelli; Maria Rosalia Pasca; Christian Lherbet; Chantal Carayon; Stéphane Massou; Michel Baron; Michel Baltas
Journal:  Molecules       Date:  2017-09-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.